comparemela.com

Latest Breaking News On - Royal victorian eye - Page 12 : comparemela.com

Syphilis epidemic in Melbourne suburbs: scientists use genomic sequencing to track STD

Syphilis epidemic in Melbourne suburbs: scientists use genomic sequencing to track STD We’re sorry, this service is currently unavailable. Please try again later. Dismiss Save Normal text size Advertisement Scientists will use genomic sequencing for the first time to track fast-moving syphilis outbreaks infiltrating Melbourne’s outer suburbs, as doctors warn immediate intervention is needed to contain an evolving epidemic of the sexually transmitted disease. Doctors at the Royal Victorian Eye and Ear Hospital are also reporting a 20-fold increase in people presenting with syphilis-related eye infections. There has been a rise in syphilis cases in Victoria. A rising number of Victorians are also being admitted to the hospital with delayed diagnosis of ocular syphilis and some are being left with permanent vision loss.

Australia s first investigational gene therapy trials for dry age-related macular degeneration under way

Centre for Eye Research Australia Australia’s first clinical trials of an investigational gene therapy to treat dry age-related macular degeneration (AMD) have begun at the Centre for Eye Research Australia (CERA). CERA’s Principal Investigator of Retinal Gene Therapy Research and vitreoretinal surgeon Dr Tom Edwards performed the first surgeries to administer the investigational gene therapy to patients at the Royal Victorian Eye and Ear Hospital in Melbourne. This investigational gene therapy, being developed by Gyroscope Therapeutics Limited, is being studied in two studies evaluating its safety and effectiveness for the treatment of geographic atrophy (GA) secondary to AMD.

Bionic Vision Technologies Advances Clinical Program With AU$1 million Medical Research Future Fund Grant

Bionic Vision Technologies Advances Clinical Program With AU$1 million Medical Research Future Fund Grant News provided by Share this article Share this article MELBOURNE, Australia, Feb. 16, 2021 /PRNewswire/ Bionic Vision Technologies (BVT) has started work on the next phase of development for its world-leading Australian bionic eye technology thanks to a recent Australian Government grant to refine its vision processing algorithms. BVT s bionic eye is designed for people with the inherited retinal disease retinitis pigmentosa for which there is no current cure. Clinical study data from patients implanted with the device show the prosthesis is safe and gives significant improvements to functional vision and quality of life. Users reported an improved awareness of external objects and surroundings.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.